Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.

Saved in:
Bibliographic Details
Title: Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
Authors: Kreijne, J. E.1,2 (AUTHOR) j.kreijne@erasmusmc.nl, Goetgebuer, R. L.1 (AUTHOR), Erler, N. S.3,4 (AUTHOR), De Boer, N. K.2 (AUTHOR), Siebers, A. G.5 (AUTHOR), Dijkstra, G.6 (AUTHOR), van Kemenade, F. A.7 (AUTHOR), Hoentjen, F.8,9 (AUTHOR), Oldenburg, B.10 (AUTHOR), van der Meulen, A. E.11 (AUTHOR), Ponsioen, C. I. J.12 (AUTHOR), Pierik, M. J.13 (AUTHOR), van der Woude, C. J.1 (AUTHOR), de Vries, A. C.1 (AUTHOR) a.c.devries@erasmusmc.nl
Source: Alimentary Pharmacology & Therapeutics. Jul2023, Vol. 58 Issue 2, p207-217. 11p. 1 Diagram, 4 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.17555